Indeed, serum SAA concentrations of T2D patients are significantly increased, ranging from 2.1-24 μg/mL, which is comparable to levels observed in obese individuals [150,154,155,156]. This evidence concerns the gene SAA1 and type 2 diabetes mellitus.